pharma news

News

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity drug HM17321.

News

EC greenlights Acadia’s DAYBU for Rett Syndrome in Europe

Acadia Pharmaceuticals has secured EC approval for DAYBU (trofinetide) for the neurobehavioural symptoms of Rett syndrome in the EU.

News

Japan first approval for GSK’s bepirovirsen for CHB

Japan has approved GSK's antisense oligonucleoide Hibsago (bepirovirsen) as a functional cure in chronic hepatitis B virus infection in adult patients

News

UK MHRA authorises orforglipron private prescription

Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.

News

J&J scores EU approval for Tecvayli combo in second line

Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.

News

Positive Ph1 results for AC Immune's NLRP3 inflammasome inhi...

AC Immune has announced positive interim results from its Ph 1 study of ACI-19764 – a NLRP3 inflammasome inhibitor targeting chronic inflammation.

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug...

EC greenlights Acadia’s DAYBU for Rett Syndrome in Europe

Japan first approval for GSK’s bepirovirsen for CHB

UK MHRA authorises orforglipron private prescription

J&J scores EU approval for Tecvayli combo in second line

Positive Ph1 results for AC Immune's NLRP3 inflammasome inhi...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks